<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04748679</url>
  </required_header>
  <id_info>
    <org_study_id>201882</org_study_id>
    <nct_id>NCT04748679</nct_id>
  </id_info>
  <brief_title>Cognitive Behavioral Therapy (CBT) Study Evaluating the Updating of Persecutory Beliefs</brief_title>
  <official_title>Cognitive Behavioral Therapy (CBT) Study Evaluating the Updating of Persecutory Beliefs</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine how Bayesian belief updating changes throughout&#xD;
      psychotherapeutic treatment for persecutory delusions. Specifically, individuals with a&#xD;
      psychotic disorder diagnosis who endorse both a current persecutory delusion with strong&#xD;
      conviction and significant worry will be recruited and randomized to receive either a&#xD;
      CBT-based worry intervention for persecutory delusions or an active control condition&#xD;
      (befriending therapy). The investigators will examine: 1) whether belief updating parameters&#xD;
      change as delusion severity changes, 2) whether CBT contributes to greater change in belief&#xD;
      updating parameters than befriending therapy, and 3) whether neural correlates of belief&#xD;
      updating parameters, as measured using functional magnetic resonance imaging (fMRI), predict&#xD;
      treatment response.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 30, 2021</start_date>
  <completion_date type="Anticipated">September 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Computational Parameters of Belief Updating as Measured During a Probabilistic Reversal Learning Task</measure>
    <time_frame>Baseline, 4 weeks, 8 weeks, 24 weeks</time_frame>
    <description>change in computational parameters after intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Delusion Severity Utilizing the Change in Psychotic Symptoms Rating Scale (PSYRATS)</measure>
    <time_frame>Baseline, 4 weeks, 8 weeks, 24 weeks</time_frame>
    <description>The change in the Delusions subscale total of the Psychotic Symptoms Rating Scale (PSYRATS) from Baseline to Week 24. The Delusions subscale is a composite score of 6 items each rated from 0-4 with 4 indicating more severe symptomology. The Delusions subscale has a possible range of 0-24.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Neural Correlates of Belief Updating Parameters</measure>
    <time_frame>Baseline, 8 weeks</time_frame>
    <description>Change in blood oxygen dependent level (BOLD) signal after intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Baseline Neural Predictors of Treatment Response</measure>
    <time_frame>Baseline</time_frame>
    <description>BOLD signal during belief updating task at baseline predicting treatment response</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resting-State Predictors of Treatment Response</measure>
    <time_frame>Baseline</time_frame>
    <description>resting-state connectivity of functional networks predicting treatment response</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Schizophrenia; Psychosis</condition>
  <condition>Persecutory Delusion</condition>
  <arm_group>
    <arm_group_label>Worry Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Worry Intervention uses cognitive-behavioral therapy (CBT) techniques to support the patient in reducing the amount of time they worry throughout the week. It is an 8-week manualized treatment with 5 modules. Each session is 45-60 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Befriending</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Befriending therapy controls for the general factors of therapy (warmth, engagement) without any 'active' interventions. Individuals in the befriending arm will spend sessions talking with the therapist about things that interest them. It will also be conducted over 8-weeks with 45-60 minute sessions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Worry Intervention</intervention_name>
    <description>The worry intervention is weekly individual therapy with a trained therapist</description>
    <arm_group_label>Worry Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Befriending</intervention_name>
    <description>The worry intervention is weekly individual therapy with a trained therapist</description>
    <arm_group_label>Befriending</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Men and women age 18 - 65.&#xD;
&#xD;
          2. Communicative in English.&#xD;
&#xD;
          3. Premorbid Intelligence &gt;79 (WTAR)&#xD;
&#xD;
          4. Provide voluntary, written informed consent.&#xD;
&#xD;
          5. Physically healthy by medical history.&#xD;
&#xD;
          6. Weight &lt;300 lbs&#xD;
&#xD;
          7. Stable medication regimen over at least the past two weeks, including the use of&#xD;
             either an oral or intramuscular administration of an antipsychotic medication.&#xD;
&#xD;
          8. Diagnosis of a non-affective psychotic disorder (schizophrenia, schizoaffective&#xD;
             disorder, schizophreniform disorder, delusional disorder, brief psychotic disorder,&#xD;
             psychosis NOS) confirmed by Structured Clinical Interview for Diagnostic and&#xD;
             Statistical Manual (DSM)-5 (SCID) or diagnostic interview with a trained clinician.&#xD;
&#xD;
          9. A persecutory delusion scoring at least a 3 on the conviction scale of the Psychotic&#xD;
             Symptoms Rating Scale (PSYRATS) that had persisted for at least two weeks and that was&#xD;
             not considered the direct result of substance use&#xD;
&#xD;
         10. A clinically significant level of worry, as shown by a score of at least 44 on the&#xD;
             Penn State Worry Questionnaire (PSWQ).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Age less than 18 or greater than 65.&#xD;
&#xD;
          2. Not communicative in English.&#xD;
&#xD;
          3. Premorbid IQ &lt; 79 (WTAR)&#xD;
&#xD;
          4. Unable to provide written informed consent.&#xD;
&#xD;
          5. Current medical or neurological illness.&#xD;
&#xD;
          6. History of severe head trauma.&#xD;
&#xD;
          7. Weight &gt;300 lbs&#xD;
&#xD;
          8. Primary diagnosis of alcohol or substance use disorder or personality disorder&#xD;
&#xD;
          9. Conditions that preclude fMRI scanning (as defined in the fMRI Screening Form)&#xD;
&#xD;
         10. Subjects who are actively involved with individual cognitive therapy (Past experience&#xD;
             with individual therapy is not an exclusion)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Julia M Sheffield, PhD</last_name>
    <phone>6153433839</phone>
    <email>julia.sheffield@vumc.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julia Sheffield, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>February 5, 2021</study_first_submitted>
  <study_first_submitted_qc>February 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 10, 2021</study_first_posted>
  <last_update_submitted>June 10, 2021</last_update_submitted>
  <last_update_submitted_qc>June 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University Medical Center</investigator_affiliation>
    <investigator_full_name>Julia Sheffield</investigator_full_name>
    <investigator_title>Assistant Professor of Psychiatry &amp; Behavioral Sciences</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Delusions</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

